You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,751,305


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,751,305 protect, and when does it expire?

Patent 10,751,305 protects PLIAGLIS and is included in one NDA.

This patent has seven patent family members in seven countries.

Summary for Patent: 10,751,305
Title:Solid-forming topical formulations for pain control
Abstract: Solid-forming topical formulations can include a local anesthetic, an emulsifying agent, polymer, and water. The formulation can include from 0.1 wt % to 5 wt % more of the emulsifying agent, from 0.1 wt % to 20 wt % more of the polymer, and from 0.1 wt % to 30 wt % more water than a comparative formulation, and drying time is faster than the comparative formulation when applied to a skin surface and dried under the same ambient conditions.
Inventor(s): Zhang; Jie (Salt Lake City, UT), Hull; Wade (Kaysville, UT), Vo; Ngoc Truc-Chi (Longueuil, CA)
Assignee: Crescita Therapeutics Inc. (Mississauga, CA)
Application Number:15/655,595
Patent Claim Types:
see list of patent claims
Formulation;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,751,305

Introduction

United States Patent 10,751,305, like any other patent, is a complex document that outlines the invention, its claims, and the scope of protection it offers. To analyze this patent, it is crucial to delve into its various components and understand the broader patent landscape.

Patent Overview

Invention Description

The patent describes the invention in detail, including its background, summary, and detailed description. This section is critical for understanding the problem the invention solves, the prior art, and how the invention improves upon existing solutions.

Claims

The claims section is the most important part of a patent as it defines the scope of protection. Claims can be independent or dependent, and they must be clear, concise, and fully supported by the description[3].

Claim Analysis

Independent Claims

Independent claims stand alone and define the invention without reference to other claims. These claims are crucial as they set the broadest scope of protection for the invention.

Dependent Claims

Dependent claims refer back to an independent claim and further limit the scope of the invention. They often add specific details or features that narrow down the invention.

Claim Construction

The construction of claims is vital for determining patent eligibility and infringement. The USPTO's 2024 guidance update on AI patents emphasizes the importance of integrating judicial exceptions into practical applications to ensure patent eligibility[1].

Scope of Protection

Subject Matter Eligibility

The scope of protection is heavily influenced by subject matter eligibility. The 2024 USPTO guidance update clarifies that claims must integrate abstract ideas into practical applications to be eligible for patent protection. This involves assessing whether the claim imposes meaningful limits on the judicial exception, transforming it into patent-eligible subject matter[1].

Practical Applications

Highlighting real-world applications of the claimed method or system is essential. Demonstrating how the abstract idea is applied to provide concrete benefits or solve specific problems in the relevant field is crucial for establishing patent eligibility[1].

Patent Landscape

Prior Art

Understanding the prior art is essential for assessing the novelty and non-obviousness of the invention. The Patent Trial and Appeal Board (PTAB) often reviews prior art to determine if a patent's claims are anticipated or obvious[2].

Related Patents and Applications

Using tools like the USPTO's Global Dossier, one can identify related patent applications and their status across different jurisdictions. This helps in understanding the broader patent landscape and potential overlaps or conflicts[4].

Economic and Legal Implications

Patent Scope Measurements

The USPTO's Patent Claims Research Dataset provides insights into patent scope measurements, which can help in understanding the economic implications of a patent's claims. This dataset includes claim-level statistics and document-level statistics that can be used to analyze the scope and impact of a patent[3].

Small Claims Patent Court

The concept of a small claims patent court, as studied by the Administrative Conference of the United States (ACUS), could impact the enforcement and litigation landscape for patents like 10,751,305. Such a court could provide a more streamlined and cost-effective way to resolve patent disputes[5].

Case Law and Precedents

Recent Case Law

Recent case law, such as the decisions from the Court of Appeals for the Federal Circuit, can provide valuable insights into how similar claims have been treated in the past. For example, the case of Arbutus Biopharma Corporation v. Moderna Therapeutics highlights the importance of demonstrating that a claim is not anticipated by prior art[2].

Incorporation of Recent Case Law

The 2024 USPTO guidance update incorporates recent case law to provide clearer guidelines on patent eligibility. This ensures that practitioners can draft claims that are more likely to avoid section 101 rejections[1].

Drafting and Prosecution Strategies

AI-Assisted Inventions

For patents involving AI, the method of invention development does not impact subject matter eligibility. However, the focus remains on the claimed invention itself, ensuring there is significant human contribution and practical application[1].

Claim Drafting

Claims should be drafted to integrate abstract ideas into practical applications. This involves specifying the use of the invention in a way that provides tangible benefits and improves technology or provides a practical application[1].

Enforcement and Litigation

Patent Infringement

To enforce a patent, one must ensure that the claims are clear and that any infringement can be proven. The scope of protection defined by the claims is crucial in determining whether another party's product or process infringes on the patent.

Defending Against Challenges

In the event of a challenge, such as an inter partes review (IPR), the patent holder must be prepared to defend the claims against arguments of anticipation or obviousness. Understanding the prior art and the specific limitations of the claims is vital in these proceedings[2].

Key Takeaways

  • Subject Matter Eligibility: Claims must integrate judicial exceptions into practical applications to be patent-eligible.
  • Practical Applications: Highlighting real-world applications is crucial for demonstrating patent eligibility.
  • Claim Construction: Claims must be clear, concise, and fully supported by the description.
  • Prior Art: Understanding prior art is essential for assessing novelty and non-obviousness.
  • Economic Implications: Analyzing patent scope measurements can provide insights into the economic impact of a patent.

FAQs

What is the significance of integrating judicial exceptions into practical applications in patent claims?

Integrating judicial exceptions into practical applications is crucial for ensuring that a claim is patent-eligible. This involves assessing whether the claim imposes meaningful limits on the exception, transforming it into patent-eligible subject matter[1].

How does the 2024 USPTO guidance update impact AI-related inventions?

The 2024 USPTO guidance update clarifies that the method of invention development, including the use of AI, does not impact subject matter eligibility. Instead, the focus remains on the claimed invention itself, ensuring there is significant human contribution and practical application[1].

What role does prior art play in determining patent eligibility?

Prior art is essential for determining if a patent's claims are anticipated or obvious. The PTAB reviews prior art to assess the novelty and non-obviousness of the invention[2].

How can the USPTO's Global Dossier help in understanding the patent landscape?

The Global Dossier provides access to the file histories of related applications from participating IP Offices, allowing users to see the patent family for a specific application and understand the broader patent landscape[4].

What is the potential impact of a small claims patent court on patent enforcement?

A small claims patent court could provide a more streamlined and cost-effective way to resolve patent disputes, making it easier for smaller entities to enforce their patents[5].

Cited Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent Eligibility - Mintz.
  2. ARBUTUS BIOPHARMA CORPORATION v. MODERNATX, INC. - Court of Appeals for the Federal Circuit.
  3. Patent Claims Research Dataset - USPTO.
  4. Search for patents - USPTO - USPTO.
  5. U.S. Patent Small Claims Court - Administrative Conference of the United States.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,751,305

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Crescita Therap PLIAGLIS lidocaine; tetracaine CREAM;TOPICAL 021717-001 Jun 29, 2006 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.